Home

Engedetlenség eszköz elem clozel jean paul Töprengő Bögre Fahrenheit

Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News  in France
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France

Ernst and Young's world Entrepreneur Dr Jean Paul Clozel | Flickr
Ernst and Young's world Entrepreneur Dr Jean Paul Clozel | Flickr

Johnson & Johnson Vice President and Worldwide Chairman Pharmaceuticals  Joaquin Duato (L-R), Actelion CEO and founder Jean-Paul Clozel and Johnson  & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels pose for  photographers at ...
Johnson & Johnson Vice President and Worldwide Chairman Pharmaceuticals Joaquin Duato (L-R), Actelion CEO and founder Jean-Paul Clozel and Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels pose for photographers at ...

PharmaBoardroom - Jean-Paul Clozel - CEO & Co-Founder, Actelion, Switzerland
PharmaBoardroom - Jean-Paul Clozel - CEO & Co-Founder, Actelion, Switzerland

Jean-Paul und Martine Clozel - Ein Unternehmerpaar der besonderen Art -  News - SRF
Jean-Paul und Martine Clozel - Ein Unternehmerpaar der besonderen Art - News - SRF

Idorsia - first milestone reached! - Private Wealth - Private Wealth
Idorsia - first milestone reached! - Private Wealth - Private Wealth

Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not  acquisition - CEOWORLD magazine
Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not acquisition - CEOWORLD magazine

Jean-Paul Clozel | Financial Times
Jean-Paul Clozel | Financial Times

How is Actelion Spin-Off Idorsia Doing One Year Later?
How is Actelion Spin-Off Idorsia Doing One Year Later?

Jean-Paul Clozel, CEO Actelion - YouTube
Jean-Paul Clozel, CEO Actelion - YouTube

Actelion wins FDA approval for hypertension drug - San Francisco Business  Times
Actelion wins FDA approval for hypertension drug - San Francisco Business Times

Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg

Idorsia : Transforming the Horizons of Therapeutic Options | Insights Care
Idorsia : Transforming the Horizons of Therapeutic Options | Insights Care

J&J Woos Billionaire Doctors Who Don't Need Cash in Actelion Bid - Bloomberg
J&J Woos Billionaire Doctors Who Don't Need Cash in Actelion Bid - Bloomberg

Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook

Our CEO, Jean-Paul Clozel... - Idorsia Pharmaceuticals Ltd | Facebook
Our CEO, Jean-Paul Clozel... - Idorsia Pharmaceuticals Ltd | Facebook

Medical couple and butcher's boy win big from Actelion sale | Reuters
Medical couple and butcher's boy win big from Actelion sale | Reuters

Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS

Daridorexant Effective for Insomnia in Phase 3 Trial
Daridorexant Effective for Insomnia in Phase 3 Trial

Idorsia insomnia drug starts FDA review as founder Clozel's second act  proceeds | Reuters
Idorsia insomnia drug starts FDA review as founder Clozel's second act proceeds | Reuters

Jean-Paul Clozel
Jean-Paul Clozel

Biotech visionary Jean-Paul Clozel: "Previous success can be a big  handicap," - YouTube
Biotech visionary Jean-Paul Clozel: "Previous success can be a big handicap," - YouTube

Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels  (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference  at Actelion headquarters in Allschwil, Switzerland January 26, 2017.  REUTERS/Arnd Wiegmann Stock ...
Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels (L) and Actelion CEO and founder Jean-Paul Clozel attend a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Stock ...

Profile: Jean-Paul Clozel | Nature Biotechnology
Profile: Jean-Paul Clozel | Nature Biotechnology

Jean-Paul Clozel | EY - Global
Jean-Paul Clozel | EY - Global

Was plant das Ehepaar Clozel? | NZZ
Was plant das Ehepaar Clozel? | NZZ

Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock  rise and talk of partnering up for pivotal trial | Fierce Biotech
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech